The abstract is read at the publisher; the summary is JClub's.
In 71 congenital heart disease patients with medically refractory protein-losing enteropathy, combined intrahepatic plus periduodenal lymphatic embolization achieved higher initial response (87% vs 41%) and longer remission than intrahepatic embolization alone.
- Why it matters: PLE in CHD is often treated symptomatically, and prior embolization work has emphasized intrahepatic targets with inconsistent results and limited long-term data.
- What they did: In a single-center retrospective review, multicompartment magnetic resonance lymphangiography guided percutaneous embolization to either isolated intrahepatic targets (17) or combined intrahepatic plus periduodenal targets (54), with remission defined by serum albumin ≥3.0 g/dL without IV albumin or repeat intervention.
- The result: Combined IH + PD embolization was linked to higher initial response (87% vs 41%) and longer duration of remission, with duodenal leaks identified in all patients undergoing lymphangiography.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.